NCBI PubMed Centralopen access
Agomelatine as augmentation therapy with second-generation antipsychotics for negative symptoms of schizophrenia: An open-label randomised clinical trial and electroencephalogram-derived model for treatment response prediction.
computer science education
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1001215
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.